JRVR · James River Group Holdings, Ltd.

James River’s Q1 2026 results reflect a sharp reversal from profitability to loss, primarily due to $6.7 million in reinsurance reinstatement premiums tied to a single pre-2023 E&S claim — an event management explicitly attributes to legacy treaty structure, not current underwriting. While gross written premium fell 20% year-over-year — driven almost entirely by a 70% collapse in Specialty Admitted Insurance — the E&S segment remained stable, with active casualty lines growing modestly for the first time in three quarters. The reinstatement premiums distorted key ratios: the consolidated combined ratio spiked to 104.6% (vs. 99.5% in Q1 2025), but excluding that impact, it would have been 99.7%, with a loss ratio of 66.0% and expense ratio of 33.7%, both within historical ranges. Expense discipline was evident: G&A expenses dropped 10.5% overall, with steep reductions in Specialty Admitted (−46%) and Corporate (−15%), though the consolidated expense ratio rose to 35.4% due to the non-recurring reinstatement cost. Investment income increased 7% to $21.3 million, supported by higher-yielding structured securities, though bank loan volatility drove $6.6 million in net investment losses. Management emphasized continued strong submission flow and rate opportunities across casualty lines, and noted the 2023 reinsurance restructuring was designed precisely to mitigate future reinstatement volatility. The $0.01 dividend reaffirms capital return continuity but signals no near-term increase in payout scale. Tangible common equity declined only 1.3% quarter-over-quarter to $405.5 million, underscoring balance sheet resilience despite earnings pressure.